Neuroimaging in FDXR-related mitochondriopathy

Allison Lam1, Bryce D Beutler2, Siddhanth S Hegde1

  • 1Kaiser Permanente Bernard J. Tyson School of Medicine, Los Angeles, CA, USA.

Pediatric Radiology
|July 22, 2026
PubMed

Insights

Ferredoxin reductase (FDXR)-related mitochondriopathy is a rare genetic disorder. Systemic infections can trigger severe neurological symptoms and distinct brain imaging findings in affected children.

Area of Science:

  • Genetics
  • Neurology
  • Mitochondrial Diseases

Background:

  • Ferredoxin reductase (FDXR)-related mitochondriopathy is a rare autosomal recessive disorder.
  • Caused by pathogenic variants in the FDXR gene, it presents with variable clinical manifestations.
  • Typically, neuroimaging is normal, but severe symptoms can arise during systemic infections.

Purpose of the Study:

  • To describe a case of FDXR-related mitochondriopathy with distinct neuroimaging findings following a respiratory illness.
  • To highlight the importance of early recognition and management to prevent vision loss and improve outcomes.

Main Methods:

  • Case report of a 2-year-old female with genetically confirmed FDXR-related mitochondriopathy.
  • Detailed clinical and neuroimaging analysis, including diffusion restriction, parenchymal atrophy, and optic nerve changes.

Main Results:

  • The patient developed distinct diffusion restriction, rapid parenchymal atrophy, and optic nerve changes after a respiratory illness.
  • These findings represent a specific pattern of central nervous system involvement in FDXR-related mitochondriopathy precipitated by infection.

Conclusions:

  • FDXR-related mitochondriopathy can present with severe neurological complications and characteristic imaging findings following systemic infections.
  • Early diagnosis and intervention are crucial for managing this rare condition and improving patient outcomes, particularly regarding vision preservation.

Related Concept Videos